Last Price Today's Change   Day's Range   Trading Volume
3.20   -0.05 (1.54%)  3.20 - 3.25  101,800
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.


Market Cap: 1,521 Million
NOSH: 475 Million
Avg Volume (4 weeks):70,711
4 Weeks Range:3.20 - 3.48
4 Weeks Price Volatility (%):
52 Weeks Range:1.77 - 4.55
52 Weeks Price Volatility (%):
Average Price Target: 3.31
Price Target Upside/Downside: +0.11
Stamp duty exempted for year 2021

Financial Highlight

Latest Quarter | Ann. Date 31-Dec-2020 [#4]  |  25-Feb-2021
Next QR | Est. Ann. Date: 31-Mar-2021  |  21-May-2021
T4Q P/E | EY: 27.15  |  3.68%
T4Q DY | Payout %: 1.40%  |  37.98%
T4Q NAPS | P/NAPS: 0.9855  |  3.25
T4Q NP Margin | ROE: 8.02%  |  11.96%


Date Subject
01-Mar-2021 Apex Healthcare - All systems go
26-Feb-2021 Apex Healthcare - Prospects remain bright
26-Feb-2021 Apex Healthcare - Downgrading: Slower-than-expected Revenue Recovery
04-Feb-2021 Apex Healthcare - Orthopaedics for muscles of growth
18-Jan-2021 [转贴] 医疗物流领域摩拳擦掌 疫苗概念股走俏
23-Nov-2020 Company Update - Apex Healthcare - Upgrading to HOLD
20-Nov-2020 Apex Healthcare Berhad - Uncertainties Ahead
20-Nov-2020 Mplus Market Pulse - 20 Nov 2020
27-Aug-2020 Apex Healthcare Berhad- No Surprises
27-Aug-2020 Apex Healthcare - Earnings Holding Up Well
24-Jul-2020 下跌股:Apex保健 RM2.83支撑
23-Jul-2020 上升股:Apex保健 阻力RM4.88
22-Jul-2020 疫苗有望年杪推出·制药股狂飙
10-Jul-2020 大马股票 | APEX保健 | AHEALTH | 从零开始了解APEX保健 - 少爷兵
17-Jun-2020 下跌股:APEX保健RM2.68支撑
22-May-2020 Apex Healthcare Berhad- Overall Still Healthy
22-May-2020 Apex Healthcare - Covid-19-induced Demand Lifted Sales and Profit
22-May-2020 Mplus Market Pulse - 27 May 2020
15-May-2020 Trading Stocks - Apex Healthcare
13-Apr-2020 Trading Stocks - Apex Healthcare

Business Background

Apex Healthcare Bhd is a public limited liability company, incorporated and domiciled in Malaysia. The Company is an investment holding company for a group of companies engaged in the business of manufacturing, marketing, distributing and retailing of pharmaceuticals, diagnostics, orthopaedics and consumer healthcare products with direct operations in Malaysia, Singapore and Vietnam. Its operations are organized into three segments: Manufacturing and Marketing, Wholesale and Distribution, and Corporate.
Analyze this stock with MQ Trader system

  4 people like this.
serendipity89 https://www.theedgemarkets.com/article/apex-healthcare-ready-play-role-vaccine-distribution
11/11/2020 8:48 AM
JaBerry People jump to vaccine company. Do we realise without supply chain and logistics also problem? Apex play important roles and has facilities and temperature control in distributing the vaccine.
11/11/2020 9:52 AM
NPRA1985 China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

13/11/2020 9:54 PM
Sinoboy If moderna vaccine is for real, apex health can play a substantial role. Apparently, moderna's vaccine requires storage of only -20C. This is exactly what apex health has, storage facilities that meet this requirement.
Hopefully, such important information is not lost on the public. This counter has great potential
16/11/2020 8:17 PM
Russell Eventually vaccine makers will need to come to Apex Healthcare for its cold chain facility which will be completed in Q4. It just completed it’s cold chain in Singapore. Perfect stock for the recovery trend
16/11/2020 9:13 PM
Sinoboy Hopefully today's uptrend can be maintained...
19/11/2020 6:13 PM
serendipity89 profit seems to have recovered back to pre covid level. next to see is after they completed their cold chain network, whehter they are able to secure distribution contract for the vaccine.
19/11/2020 7:46 PM
Mr.Sm Invest123 Apex Pharma

On 14th September, the Group’s wholly owned manufacturing subsidiary Xepa-Soul Pattinson (M) Sdn Bhd secured renewal of its GMP status with the National Pharmaceutical Regulatory Authority (‘NPRA’) through a scheduled desktop audit. In the quarter, Apex Pharma Marketing Pte Ltd in Singapore increased its cold chain distribution capabilities with the expansion of its current 2-8 degrees C cold room and the acquisition of a -20 degrees C freezer room for pharmaceuticals, vaccines and biologics. Expansion of cold chain distribution capacity in Malaysia is scheduled for completion before the end of the current financial year.
Review of Year To Date Performance versus Corresponding Period Last Year
20/11/2020 12:05 AM
20/11/2020 12:06 AM
DreamGuardian Up 8 sen
20/11/2020 12:06 AM
DreamGuardian Up 2.27%
20/11/2020 12:06 AM
DreamGuardian Okay also la
20/11/2020 12:07 AM
DreamGuardian Boleh juga la
20/11/2020 12:07 AM
DreamGuardian Keep surging
20/11/2020 12:07 AM
DreamGuardian Good luck
20/11/2020 12:07 AM
Mr.Sm Invest123 Tomorrow Fly over 4.50
20/11/2020 12:10 AM
Mr.Sm Invest123 Accumulating more
20/11/2020 12:20 AM
Sinoboy Looking good. Steady she goes, don't falter
20/11/2020 11:52 AM
chshzhd keep..
20/11/2020 4:59 PM
JaBerry Yes keep
23/11/2020 9:22 AM
NPRA1985 Post removed. Why?
23/11/2020 2:00 PM
JaBerry Waiting for vaccines come another distribution income.
27/11/2020 9:36 AM
mrmeow AHEALTH has the cold storage facility and has expanded by acquiring more cold facility and prepared for the covid19 vaccines. Don't foget this real making money one, supplying Msia and Singapore, stable & growing business even before covid, always on an uptrend
27/11/2020 9:41 AM
mrmeow Everyone looking for logistics company that has cold facility for vaccine distribution, yet they forget that this pharmaceutical company does distribution too and has the logistics capable of doing the real work
27/11/2020 12:00 PM
Mr.Sm Invest123 Vaccine-related: Following the approval of Budget 2021, vaccine-related companies will benefit under the Covid-19 fund/fill-and-finish process as well as distribution of vaccines once it is available in the future. Under this segment, SOLUTN, HWGB, BINTAI, DPHARMA, PHARMA, KANGER, -Ahealth, TITIJYA, MAHSING should be under traders radar.

Source: M+ Online
27/11/2020 12:47 PM
serendipity89 ''Apex has been approached by several manufacturers to be the authorised distributor for their upcoming Covid-19 vaccines (work-in-progress). There are many considerations in evaluating these proposals (ie. whether the products will be approved, pricings, efficiencies, requirements, etc) and hence, Apex has not committed to any manufacturer. Instead, the group will likely start off as a wholesaler, where Apex will distribute the Covid-19 vaccines from various manufacturers''

28/11/2020 1:30 PM
NPRA1985 PM: No call to reject 2021 Budget just to bring about polls

"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.

"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.

Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.

"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."

29/11/2020 9:25 PM
NPRA1985 No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

29/11/2020 9:36 PM
weijuin1992 Buy on rumours sell on fact ,it had come so far with rumours ,once confirm news will fly ,sit in if you believe in good company !
01/12/2020 12:08 PM
weijuin1992 Reversal to uptrend on small fraction of price yet big indicator to this share as it is not so volatile like the others , good chance striking up again !
01/12/2020 5:39 PM
NPRA1985 U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.

02/12/2020 6:36 PM
NPRA1985 Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

03/12/2020 12:36 AM
NPRA1985 US says Covid-19 vaccines ready to be shipped nationwide immediately

03/12/2020 12:37 AM
NPRA1985 Janssen seeks Health Canada approval for its COVID-19 vaccine

03/12/2020 12:37 AM
NPRA1985 Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

03/12/2020 12:38 AM
NPRA1985 Promise of Covid vaccines is ‘phenomenal’, WHO says

03/12/2020 10:25 PM
NPRA1985 Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets

03/12/2020 10:47 PM
NPRA1985 DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.

05/12/2020 1:33 AM
NPRA1985 South Korea reaches deal to buy AstraZeneca's Covid-19 vaccine candidate

05/12/2020 1:46 AM
NPRA1985 500 million vaccine doses in Q1 2021 closer to reality, says WHO

05/12/2020 2:34 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

09/12/2020 3:12 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

09/12/2020 10:25 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

10/12/2020 11:55 PM
NPRA1985 FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar

(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.

The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.

"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.

12/12/2020 2:26 AM
NPRA1985 Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

12/12/2020 3:04 PM
NPRA1985 Bursa Malaysia is expected to trend higher next week



Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

12/12/2020 6:05 PM
FT1981 this counter not active?
07/01/2021 11:19 AM
FT1981 https://app.sinchew.com.my/content/content_2406317.html?type=detail&fileId=2406317&colID=6660
07/01/2021 11:20 AM
NPRA1985 Post removed. Why?
03/02/2021 10:03 PM
KaiHong this is a stable stock
15/02/2021 3:00 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards

350  546  616  1093 

Top 10 Active Counters
 ITRONIC 0.675+0.195 
 GFM-WC 0.12+0.045 
 DNEX-WD 0.3750.00 
 ARMADA 0.425+0.03 
 KOMARK-WC 0.115+0.01 
 JADI 0.125+0.015 
 DNEX 0.74+0.02 
 KOMARK 0.66+0.095 
 VELESTO 0.17+0.005 
 GFM 0.275+0.07 


1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!